PROMEDIUS
Songpadong · Founded 2019
About PROMEDIUS
Founded in 2019, Promedius stands at the forefront of redefining the aging process through innovative solutions for the early detection and management of musculoskeletal and metabolic diseases, including osteoporosis. Driven by our vision to delay aging through AI, we are dedicated to enhancing the quality of life and extending the healthy lifespan of individuals. Our product, PROS® CXR:OSTEO, represents the world’s first screening solution that leverages chest X-ray images to identify patients who may be at risk of osteoporosis.
Company Facts
- Founded: 2019
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $10.6M
- Funding stage: Early Stage Venture
- Last round: Grant (Sep 2025)
- Website: http://promedius.ai
- Phone: +82-2-423-8511
Industries & Categories
Artificial Intelligence (AI), Medical, Software
Social Profiles
Canonical: https://fsome.com/organization/promedius-66034 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.